Are we near to the end of the standard dose of micafungin?

Are we near to the end of the standard dose of micafungin?

Bibliographic Details
Main Authors:	Alexander Agrifoglio, Lucía Cachafeiro, Eva Herrero, Manuel Sánchez, Abelardo García de Lorenzo
Format:	Article
Language:	English
Published:	BMC 2018-06-01
Series:	Critical Care
Subjects:	Micafungin Pharmacokinetic Candida
Online Access:	http://link.springer.com/article/10.1186/s13054-018-2068-z

Similar Items

A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
by: Filippo Pieralli, et al.
Published: (2014-07-01)

In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates
by: Maede Salehi, et al.
Published: (2022-03-01)

A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin
by: Kento Furuya, et al.
Published: (2023-05-01)

A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection
by: Yuta Norimatsu, et al.
Published: (2017-06-01)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
by: Fazal Shirazi, et al.
Published: (2015-10-01)

Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
by: Saeed Alqahtani, et al.
Published: (2021-11-01)

Candida glabrata hospital isolate from Lebanon reveals micafungin resistance associated with increased chitin and resistance to a cell-surface-disrupting agent
by: Nour Fattouh, et al.
Published: (2024-06-01)

Micafungin Is an Efficient Treatment of Multi Drug-Resistant <i>Candida glabrata</i> Urosepsis: A Case Report
by: Zuzana Javorova Rihova, et al.
Published: (2021-09-01)

The activity of micafungin against clinical isolates of non-albicans Candida spp.
by: Biernasiuk Anna, et al.
Published: (2015-03-01)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
by: Victoria C. Grant, et al.
Published: (2022-02-01)

Fungal arthritis with adjacent osteomyelitis caused by Candida pelliculosa: a case report
by: Kwang Yun Song, et al.
Published: (2020-06-01)

A case of immune complex type hemolytic anemia induced by initial micafungin administration
by: Hiroto Ishii, et al.
Published: (2022-09-01)

Micafungin Effectiveness in Treating Pediatric Patients with Proven Candidemia
by: Kamile Ötiken Arıkan, et al.
Published: (2022-12-01)

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01)

Antiviral effects of micafungin against pteropine orthoreovirus, an emerging zoonotic virus carried by bats
by: Eiichi Hondo, et al.
Published: (2024-01-01)

Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
by: Maria Kotsopoulou, et al.
Published: (2019-02-01)

The Fungicidal Action of Micafungin is Independent on Both Oxidative Stress Generation and HOG Pathway Signaling in <i>Candida albicans</i>
by: Rebeca Alonso-Monge, et al.
Published: (2020-11-01)

Micafungin Inhibits Dengue Virus Infection through the Disruption of Virus Binding, Entry, and Stability
by: Yen-Chen Chen, et al.
Published: (2021-04-01)

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of <i>Candida parapsilosis</i> and Elevation of Micafungin MICs in Non-<i>parapsilosis Candida</i> Species
by: Yasutaka Sakamoto, et al.
Published: (2021-07-01)

Micafungin effect on Pseudomonas aeruginosa metabolome, virulence and biofilm: potential quorum sensing inhibitor
by: Duaa M. Hijazi, et al.
Published: (2023-02-01)

Cutaneous phototoxic reaction to intravenous micafungin in the outpatient setting: A case report
by: Arthur Price, et al.
Published: (2021-07-01)

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
by: Alexandra Mpakosi, et al.
Published: (2016-06-01)

Improving the production of the micafungin precursor FR901379 in an industrial production strain
by: Ping Men, et al.
Published: (2023-03-01)

Do <i>Candida albicans</i> Isolates with Borderline Resistant Micafungin MICs Always Harbor <i>FKS1</i> Hot Spot Mutations?
by: Kathrin Spettel, et al.
Published: (2021-01-01)

Does DHN-Melanin Always Protect Fungi against Antifungal Drugs? The <i>Fonsecaea</i>/Micafungin Paradigm
by: Rowena Alves Coelho, et al.
Published: (2022-05-01)

Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study
by: Antonio Vena, et al.
Published: (2020-02-01)

Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
by: Shogo Nakajima, et al.
Published: (2023-02-01)

Development and Validation of a Stability-Indicating High Performance Liquid Chromatographic (HPLC) Method for the Determination of Related Substances of Micafungin Sodium in Drug Substances
by: Zuyue Sun, et al.
Published: (2013-10-01)

Effects of resveratrol on macrophages after phagocytosis of Candida glabrata
by: Zong-Han Chen, et al.
Published: (2023-11-01)

Prospective Study on Prophylactic Micafungin Sodium against Invasive Fungal Disease during Neutropenia in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Bo-Kyung Kim, et al.
Published: (2022-03-01)

Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial
by: Shun-ichi Kimura, et al.
Published: (2020-11-01)

Micafungin-Induced Cell Wall Damage Stimulates Morphological Changes Consistent with Microcycle Conidiation in <i>Aspergillus nidulans</i>
by: Samantha Reese, et al.
Published: (2021-06-01)

Susceptibility of the <i>Candida haemulonii</i> Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review
by: Lívia S. Ramos, et al.
Published: (2020-10-01)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
by: Francis Vekeman, et al.
Published: (2018-08-01)

Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan
by: Daiki Yasunaga, et al.
Published: (2017-12-01)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
by: Sepideh Mehravar, et al.
Published: (2024-03-01)

Caspofungin Inhibits Mixed Biofilms of Candida albicans and Methicillin-Resistant Staphylococcus aureus and Displays Effectiveness in Coinfected Galleria mellonella Larvae
by: Gaby Scheunemann, et al.
Published: (2021-10-01)

Efficacy of LAMB against Emerging Azole- and Multidrug-Resistant <i>Candida parapsilosis</i> Isolates in the <i>Galleria mellonella</i> Model
by: Ulrike Binder, et al.
Published: (2020-12-01)

Histological Effects of Intravitreal Injection of Antifungal Agents in New Zealand White Rabbits: An Electron Microscopic and Immunohistochemical Study
by: Sofia Karachrysafi, et al.
Published: (2020-09-01)

The Effects of Intravitreal Administration of Antifungal Drugs on the Structure and Mechanical Properties Peripheral Blood Erythrocyte Surface in Rabbits
by: Maria N. Starodubtseva, et al.
Published: (2022-09-01)